Novartis Ag Nvs Ceo Vas Narasimhan On Q2 2022 Final Results Earnings Get In Touch With Transcript
Most pharmaceutical firms are ultimately confronted with a comparable challenge. There’s never been a great model for how a company in our industry can get by means of this transition. When I was appointed to lead the pharmaceuticals division, just six...